LobbyingThe Society of Thoracic Surgeons lobbying by quarter
The Society of Thoracic Surgeons's latest lobbying report covers Q2 2026, at $182.6K. The four quarters Q4 2025–Q3 2026 total $699.8K. Its first report covers Q4 2022; the issues it reports most are Education and Labor Issues/Antitrust/Workplace.
The Society of Thoracic Surgeons
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $699.8K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $21K | 1 |
| Q1 2023 | $100.9K | 1 |
| Q2 2023 | $121.2K | 1 |
| Q3 2023 | $136.6K | 1 |
| Q4 2023 | $229.8K | 1 |
| Q1 2024 | $158.3K | 1 |
| Q2 2024 | $179.3K | 1 |
| Q3 2024 | $157.7K | 1 |
| Q4 2024 | $105.4K | 1 |
| Q1 2025 | $261.1K | 1 |
| Q2 2025 | $156K | 1 |
| Q3 2025 | $135.9K | 1 |
| Q4 2025 | $183.6K | 1 |
| Q1 2026 | $333.6K | 1 |
| Q2 2026 | $182.6K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Education$490.9K · 14 reports
- Labor, antitrust and workplace$490.9K · 14 reports
- Medical research and clinical labs$490.9K · 14 reports
- Medicare and Medicaid$490.9K · 14 reports
- Health issues$307.2K · 9 reports
- Defense$171.4K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
- Centers For Medicare and Medicaid Services (CMS)9 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseThe Society of Thoracic Surgeons | $2.5M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $182.6K |
| 04/20for Q1 | In-house | $333.6K |
| 01/20for Q4 2025 | In-house | $183.6K |
| 25/10/20for Q3 2025 | In-house | $135.9K |
| 25/07/21for Q2 2025 | In-house | $156K |
| 25/04/22for Q1 2025 | In-house | $261.1K |
| 25/01/21for Q4 2024 | In-house | $105.4K |
| 24/10/21for Q3 2024 | In-house | $157.7K |
| 24/07/24for Q2 2024 | In-house | $179.3K |
| 24/04/22for Q1 2024 | In-house | $158.3K |
| 24/01/19for Q4 2023 | In-house | $229.8K |
| 23/10/19for Q3 2023 | In-house | $136.6K |
| 23/07/20for Q2 2023 | In-house | $121.2K |
| 23/04/20for Q1 2023 | In-house | $100.9K |
| 23/02/08for Q4 2022 | In-house | $21K |